Spyre Therapeutics

SYRE

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-208.57M

EBITDA$-207.97M

EBIT$-207.97M

Pre-tax Income$-179.44M

Net Income$-208.02M

Cash Equivalent$108.58M

Total Debt$0

Book Value$406.31M

Book Value Per Share9.10

Return on Equity (ROE)-40.17%

Return on Assets (ROA)-34.19%

Return on Invested Capital (ROI)-40.17%

Net Profit Margin-38238.15%

Current Ratio11.26

Quick Ratio11.16

Long-Term Debt / Equityundefined